sulfamethoxypyridazine has been researched along with Hemolysis in 2 studies
Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Thornhill, M | 1 |
Pemberton, M | 1 |
Buchanan, J | 1 |
Theaker, E | 1 |
Stavem, P | 1 |
Strömme, J | 1 |
Lorkin, PA | 1 |
Lehmann, H | 1 |
1 trial available for sulfamethoxypyridazine and Hemolysis
Article | Year |
---|---|
An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid.
Topics: Aged; Anti-Infective Agents; Drug Hypersensitivity; Female; Hemolysis; Humans; Male; Middle Aged; Mo | 2000 |
1 other study available for sulfamethoxypyridazine and Hemolysis
Article | Year |
---|---|
Haemoglobin M Saskatoon with slight constant haemolysis, markedly increased by sulphonamides.
Topics: Adult; Blood Protein Electrophoresis; Chromatography, Ion Exchange; Cyanides; Cyanosis; Hemoglobins, | 1972 |